PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.520.06 (-1.08%)
5.46 - 5.56
4.95 - 8.28
1.7K / 2.4K (Avg.)
-276.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
14.46%
Revenue growth above 1.5x UPM.HE's 4.31%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-41.81%
Negative gross profit growth while UPM.HE is at 24.43%. Joel Greenblatt would examine cost competitiveness or demand decline.
14800.00%
EBIT growth above 1.5x UPM.HE's 13.58%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
14800.00%
Operating income growth above 1.5x UPM.HE's 13.58%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
445.83%
Net income growth above 1.5x UPM.HE's 70.00%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
444.12%
EPS growth above 1.5x UPM.HE's 70.00%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
444.12%
Diluted EPS growth above 1.5x UPM.HE's 70.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.13%
Share reduction while UPM.HE is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.13%
Reduced diluted shares while UPM.HE is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-106.36%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-150.08%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-0.63%
Negative 10Y revenue/share CAGR while UPM.HE stands at 5.65%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-1.75%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-1.70%
Negative 3Y CAGR while UPM.HE stands at 18.17%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
57.19%
10Y OCF/share CAGR above 1.5x UPM.HE's 25.99%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-121.47%
Negative 5Y OCF/share CAGR while UPM.HE is at 4.69%. Joel Greenblatt would question the firm’s operational model or cost structure.
-147.18%
Negative 3Y OCF/share CAGR while UPM.HE stands at 54.38%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-45.61%
Negative 10Y net income/share CAGR while UPM.HE is at 39.93%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-78.25%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-79.10%
Negative 3Y CAGR while UPM.HE is 21.43%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
109.02%
10Y equity/share CAGR above 1.5x UPM.HE's 50.98%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
36.19%
5Y equity/share CAGR above 1.5x UPM.HE's 13.71%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
20.75%
3Y equity/share CAGR at 75-90% of UPM.HE's 25.51%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
17.70%
AR growth is negative/stable vs. UPM.HE's 54.98%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
11.16%
Inventory growth well above UPM.HE's 1.74%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-2.21%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-7.35%
We have a declining book value while UPM.HE shows 2.39%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
0.78%
We have some new debt while UPM.HE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-7.04%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.